4‑FN PET/CT scans to detect and track chronic graft‑versus‑host disease in joints

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 2 pilot enrolls adults with chronic GVHD, especially those with joint involvement, and administers the PET tracer 4‑[18F]4FN followed by PET/CT imaging to map tracer uptake. Investigators will compare imaging signals (including SUV intensity and anatomical localization) with concurrent clinical signs and measures of GVHD severity and will track whether imaging changes precede clinical manifestations. Safety and side effects of the tracer will be recorded alongside imaging correlation data. The trial is single-center at MD Anderson and allows participants who are receiving or starting systemic therapy for chronic GVHD.

Why it matters

Who can join: the full rules

Eligibility Criteria

1. Acute or Chronic GVHD - acute and chronic GVHD criteria can be found at (Harris, Young et al. 2016)(Jagasia, et al. 2015).
2. Able to give written informed consent.
3. ≥18 years of age
4. Creatinine clearance ≥ 30 mL/min/1.73m2
5. Subjects may be planned to receive a new systemic therapy for GVHD
6. Prior / continuing systemic therapy for acute or chronic GVHD is allowed
7. KPS ≥ 20
8. Ability to understand and the willingness to sign a written informed consent document.
9. The effects of the study agent on the developing human fetus are unknown. For this reason, women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation. (Refer to Pregnancy Assessment Policy MD Anderson Institutional Policy # CLN1114). This includes all female patients, between the onset of menses (as early as 8 years of age) and 55 years unless the patient presents with an applicable exclusionary factor which may be one of the following:

   * Postmenopausal (no menses in greater than or equal to 12 consecutive months).
   * History of hysterectomy or bilateral salpingo-oophorectomy.
   * Ovarian failure (Follicle Stimulating Hormone and Estradiol in menopausal range, who have received Whole Pelvic Radiation Therapy).
   * History of bilateral tubal ligation or another surgical sterilization procedure.

     * Approved methods of birth control are as follows: Hormonal contraception (i.e. birth control pills, injection, implant, transdermal patch, vaginal ring), Intrauterine device (IUD), Tubal Ligation or hysterectomy, Subject/Partner post vasectomy, Implantable or injectable contraceptives, and condoms plus spermicide. Not engaging in sexual activity for the total duration of the trial and the drug washout period is an acceptable practice; however periodic abstinence, the rhythm method, and the withdrawal method are not acceptable methods of birth control. Should a woman become pregnant or suspect she is pregnant while she or her partner is participating in this study, she should inform her treating physician immediately.
10. Men treated or enrolled on this protocol must also agree to use adequate contraception prior to the study, for the duration of study participation, and 4 months after completion of study agent administration.

Exclusion Criteria

1. Unable to comply with all study procedures (for example, participants who are unable to come to all follow up visits because they live far away from the transplant center)
2. Pregnant or lactating women: pregnant women are excluded from this study because the effects of \[18F\]4FN in pregnancy are not known.
3. Subjects with contraindications to the use of \[18F\]4FN including confirmed allergy.
4. Participants with a body weight of 400 pounds or more, or a body habitus which precludes their entry into the bore of the PET/CT scanner, because the hardware is not intended to support that weight.
5. Any additional medical condition, serious concurrent illness, or other extenuating circumstance that, in the opinion of the investigator, may significantly interfere with study compliance.
6. Children below the age of 18 are excluded because of the unknown but potential risks of administration of radiopharmaceuticals to minors.

Where it's running

• MD Anderson Cancer Center
  Houston, Texas, United States Recruiting

Study contacts

• Principal investigator: George L Chen, MD — M.D. Anderson Cancer Center
• Study coordinator: George L Chen, MD
• Email: glchen1@mdanderson.org
• Phone: 713-792-3630

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Early pregnancy lifestyle patterns and glucose changes in a TOFFFY sub-study

  This study tests whether daily patterns like sleep, activity, and meal timing in early pregnancy affect glucose levels and the risk of gestational diabetes, using CGM and wearable data in pregnant women in Singapore.

  Recruiting KK Women's and Children's Hospital · Singapore, Singapore · NCT07534670

• Opioid-free versus usual discharge pain plans after major orthopedic surgery.

  This pilot trial will test whether sending adults home after major orthopedic surgery with an opioid-free pain prescription provides pain control similar to the usual opioid-containing prescription.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT07265557

• Optimizing Rivaroxaban Dosing for Children with Giant Coronary Aneurysms After Kawasaki Disease

  This study is testing a new way to dose a blood thinner called rivaroxaban for Chinese children with giant coronary aneurysms after Kawasaki disease to see if it helps prevent heart problems.

  Recruiting Phase 4 Children's Hospital of Fudan University · Shanghai, Shanghai Municipality · NCT06978439

• Targeted PET/CT Imaging for Non-Small Cell Lung Cancer

  This study is testing a new imaging agent to see if it can help identify which patients with non-small cell lung cancer might benefit from targeted therapies based on a specific cancer marker.

  Recruiting Harbin Medical University · Harbin, Heilongjiang · NCT06911697

• Investigating flow-controlled ventilation during robot-assisted laparoscopic surgery

  This study is testing if a new way of helping patients breathe during robot-assisted surgery can make it safer for those at risk of lung problems after the operation.

  Recruiting Cantonal Hospital of St. Gallen · Innsbruck, Tyrol and 2 other locations · NCT06703814

• Evaluating group medical visits for anxiety and depression treatment

  This study is testing if virtual group sessions can help people with anxiety and depression feel better compared to regular one-on-one psychiatric care.

  Recruiting University of Manitoba · Winnipeg, Manitoba · NCT06651801

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.